Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Visiongain Report Looks at Opportunities within the $45bn Drug Discovery Outsourcing Market

This image opens in the lightbox

News provided by

Visiongain

10 Jun, 2019, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

- Global Drug Discovery Outsourcing Market Forecast to 2028

- Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening

LONDON, June 10, 2019 /PRNewswire/ -- The global drug discovery outsourcing market is estimated to have reach $22.69bn in 2018, dominated by the chemistry services segment. The global drug discovery outsourcing market is expected to grow at a CAGR of 11.7% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 195-page report you will receive 114 charts– all unavailable elsewhere.

The 195-page report provides clear detailed insight into the global drug discovery outsourcing market. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-drug-discovery-outsourcing-market-forecast-to-2028/#download_sampe_div

Report Scope

• Global Drug Discovery Outsourcing Market revenues forecasts to 2028

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Service Type:
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification & Screening

• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Regional and National Market:
• North America: U.S, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• LAMEA: Brazil, Saudi Arabia, Republic of South Africa, Rest of LAMEA

Each regional market is further segmented by submarket: chemistry services, biology services, lead optimisation, lead identification & screening.

• This report profiles and discusses the selected leading companies:
• Albany Molecular Research (AMRI)
• Aptuit, LLC
• Charles River Laboratories, Inc.
• Covance, Inc.
• Cyprotex plc
• Domainex
• Evotec AG
• GenScript
• IQVIA (QuintilesIMS)
• Laboratory Corporation of America
• Pharmaceutical Product Development (PPD)
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec

The report provides financial performance, service offerings, strategic moves & development, mergers & acquisitions.

• A SWOT analysis and Porter's Five Forces Analysis of the Drug Discovery Outsourcing market.

• Key Questions Answered by this Report:
• How is the Drug Discovery Outsourcing Market evolving?
• What are the drivers and restraints for the growth of the Drug Discovery Outsourcing Market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• How will the market shares for each drug discovery outsourcing submarket develop to 2028?
• What is the value of the leading drug discovery outsourcing submarkets in important regions of the world?
• What will be the main driver for the overall market to 2028?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market by 2028?
• Who are the leading players and what are their prospects over the forecast period?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-drug-discovery-outsourcing-market-forecast-to-2028/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

Acurian
Advion Bioanalytical Labs
Albany Molecular Research, Inc. (AMRI)
Alexion
Almirall, S.A.
Antengene Corporation
Anthem Bio Science
Apredica
Aptuit
Argenta
Ark Therapeutics
Asclepia
Astex
AstraZeneca
Aurora Fine Chemicals
Auspherix
AutoGenomics
Awridian
Bayer AG
Behrman Capital
Bio Pontis Alliance
BioCity
BioDuro
BioFocus
Bioversys AG
Boehringer Ingelheim
Brains On-Line
Bristol Myers Squibb
Bruker Daltonics
C4XDiscovery
Caprion Proteomics
Carna Biosciences, Inc.
CAS
Celgene Corporation
CENTOGENE AG
ChanTest
Charles River Laboratories, Inc.
CHDI
Chiesi Farmaceutici
Chiltern International Group Limited
Chronos Therapeutics
CISYS LifeSciences
Covance, Inc. (Laboratory Corporation of America)
Crelux GmbH
Cresset Discovery Services
CRL
Cyprotex
Daiichi Sankyo
Dalton Pharma Services
DaVita Clinical Research
Domainex
Dotmatics
Drug Discovery Alliances, Inc.
Eisai Co., Ltd.
Elan
Eli Lilly and Company
EMBL
Enamine
ERT
Eurofins Scientific
Evidera
Evotec
Exquiron Biotech
Exscientia
Forma Therapeutics
Frenova Renal Research
Galapagos
GalapagosNV
Gilead Sciences, Inc.
Great Lakes Chemical Corp.
Hangzhou Tigermed Consulting
Haplogen GmbH
HD Biosciences
HealthCore, Inc.
Hellman & Friedman
HighRes Biosolutions
Horizon
Hypha Discovery
ICON PLC
iGEM
Imperial College London
InSphero
Janssen Pharmaceuticals Inc.
Johnson & Johnson
Johnson Matthey
JOINN Laboratories
Jubilant Lifesciences
Kellogg Company
Knopp Biosciences
KWS BioTest
Laurus Labs
Lonza
Mayo Clinic
MedImmune
Merck KGaA
Microbiologics
Midwest Bio Research
Moderna Therapeutics
Molecular Sensing, Inc.
MPI Research
Nimbus Therapeutics
NovaLead Pharma Pvt. Ltd.
Novo Nordisk
Ono Pharmaceutical Co. Ltd.
ORIG3N, Inc.
Paraxel
PathoQuest
Pelago Bioscience
Petra Pharma Corporation
Pharma Nest's Genesis
Pharmidex
Piramal Group
PPD
PRA International
Proteros Biostructures GmbH
QuintilesIMS
Quotient Sciences
Rahme Lab
Regulus Therapeutics Inc.
ResearchPoint Global (RPG)
Ricerca Biosciences LLC's
Roche
Rules-Based Medicines
SAMDI Tech. Inc.
Sanofi
SARomics Biostructures
Sciformix Corporation
Selvita
SenzaGen
Shang Pharma Corporation
Sharp Edge Labs, Inc
Shin Nippon Biomedical Laboratories Ltd.
Shionogi
Siena Biotech
Signature Discovery
Sirius Analytical
Solvo Biotechnology
STA Pharmaceutical Co., Ltd.
Synthesis MedChem
TESARO, Inc.
The Carlyle Group L.P. (Albany Molecular Research Inc.)
ThermoFisher Sceintific
UCB Pharma
Viva Biotech
Vivo Path
West Lafayette
WIL Research
WIL Research Laboratories LLC
WuXi App TecCo.
WuXi Apptec
X-Chem
XtalPi Inc.

List of Organizations Mentioned in the Report
Academic Drug Discovery Consortium (ADDC)
Academy of Military Medical Sciences
Allegheny Health Network Research Institute in Pittsburgh, Duke University
AMRI
Babraham Institute
Blueprint Neurotherapeutics Network
Charité–Universitätsmedizin Berlin
Duke University
European CRO Federation
European Molecular Biology Laboratory (EMBL)
Fraunhofer Institute for Molecular Biology and Applied Ecology
Imperial College London
Indiana Clinical and Translational Sciences Institute
Marshall University
Massey Cancer Centre
Milner Therapeutics Institute
Molecular Surgical Laboratory of Massachusetts General Hospital
National Center for Advancing Translational Sciences
National Institute for Food and Drug Control
National Institute of Allergy and Infectious Disease (NIAID)
National Institutes of Health
Sanger Institute
the National Centre of Biomedical Analysis
University of California
University of Cambridge
University of Manchester
University of North Carolina
Virginia Commonwealth University, Richmond

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Biosimilars and Follow-On Biologics Market 2019-2029

Global Asthma & COPD Therapies Market 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Global Cancer Immunotherapy Market Forecast 2019-2029

Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029

Global Genomics Market Report 2018-2028

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.